Table: Stella Pharma - Q1 parent results

Stella Pharma

10/08/2022 07:20

Aug 10 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2022        Jun 30, 2021      Mar 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            46 mln               7 mln            192 mln    
                (+500.0 pct)                           (+91.8 pct)  
  Operating     loss 195 mln        loss 183 mln      loss 948 mln  
  Recurring     loss 195 mln        loss 221 mln      loss 933 mln  
  Net           loss 196 mln        loss 222 mln      loss 936 mln  
  EPS           loss 6.86 yen       loss 8.44 yen    loss 32.64 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T